Left ventricular systolic function monitoring in asymptomatic dialysis patients: A prospective cohort study

Journal of the American Society of Nephrology

Volumn 17, Issue 5, 2006, Pages 1460-1465

  Zoccali, Carmine ^a,d   Benedetto, Francesco A ^b   Tripepi, Giovanni ^a   Mallamaci, Francesca ^a   Rapisarda, Francesco ^c   Seminara, Giuseppe ^c   Bonanno, Graziella ^c   Malatino, Lorenzo S ^c  

^a CNR   (Italy)

^b Morelli Hospital   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SYSTOLIC FUNCTION; HEART MIDWALL FRACTIONAL SHORTENING; HEART VENTRICLE WALL; HEMODIALYSIS PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE COX REGRESSION ANALYSIS; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK; SYSTOLE;

EID: 33646359678     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005111240     Document Type: Article

References (25)

1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995
2. Stack AG, Bloembergen WE: A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 38: 992-1000, 2001
3. Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC: Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 41: 1267-1277, 2003
4. National Kidney Foundation: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45[Suppl 3]: S1-S154, 2005
5. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS: Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108: 977-982, 2003
6. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS: Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 15: 1029-1037, 2004
7. Wang TJ, Levy D, Benjamin EJ, Vasan RS: The epidemiology of "asymptomatic" left ventricular systolic dysfunction: Implications for screening. Ann Intern Med 138: 907-916, 2003
8. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49: 1428-1434, 1996
9. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11: 912-916, 2000
10. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7: 728-736, 1996
11. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25: 1056-1062, 1995
12. Ganau A, Devereux RB, Pickering TG, Roman MJ, Schnall PL, Santucci S, Spitzer MC, Laragh JH: Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 81: 25-36, 1990
13. Muiesan ML, Salvetti M, Monteduro C, Rizzoni D, Corbellini C, Castellano M, Porten E, Agabiti-Rosei E: Changes in midwall systolic performance and cardiac hypertrophy reduction in hypertensive patients. J Hypertens 18: 1651-1656, 2000
14. Shimizu G, ZiIe MR, Blaustein AS, Gaasch WH: Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: Overestimation of fiber velocities by conventional midwall measurements. Circulation 71: 266-272, 1985
15. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH: Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 93: 259-265, 1996
16. Devereux RB, Roman MJ, Palmieri V, Okin PM, Boman K, Gerdts E, Nieminen MS, Papademetriou V, Wachtell K, Dahlof B: Left ventricular wall stresses and wall stressmass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertension 18: 1129-1138, 2000
17. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358: 2113-2117, 2001
18. Schoenfeld D: Partial residuals for the proportional hazards regression model. Biometrika 69: 239-241, 1982
19. Therneau TM, Grambsch PM, Fleming TR: Martingale-based residuals and survival models. Biometrika 77: 216-218, 1990
20. Altman DG: Practical Statistics for Medical Research, London, Chapman and Hall, 1991, p 378
21. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277-1285, 1996
22. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS; CREED Investigators: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 12: 2768-2774, 2001
23. De Simone G: Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J Am Soc Nephrol 14: 2421-2427, 2003
24. Yudkin PL, Stratton IM: How to deal with regression to the mean in intervention studies. Lancet 347: 241-243, 1996
25. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS: Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression. Kidney Int 65: 1492-1498, 2004